Arindon, Princess Bella T.
HRN: 23-15-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2023
OXACILLIN 500MG (VIAL)
06/14/2023
06/20/2023
IV
935mg
Q6
Erysipelas Vs Cellulitis Right Leg
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes